- Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study. The Lancet. Oncology. 2017 In Process GET IT
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication.
Times cited: 53
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
Times cited: 292
- Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood. 1994 Academic Article GET IT